check_circleStudy Completed

Diagnostic imaging

Study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA in the whole body

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

5 - 82 Years
  • -

  • -

Trial summary

Enrollment Goal
388
Trial Dates
May 1987 - December 1989
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A